Clinical Trial Update: Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating a tetracaine/oxymetazoline nasal spray for endodontic treatment was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endodontic Disease
• Endodontic Inflammation

Drugs mentioned

• Tetracaine/Oxymetazoline Nasal Spray

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Endodontic Disease, Endodontic Inflammation | Phase 4 | Status: WITHDRAWN